Besides, schisandrol A could enhance the PI3K/AKT pathway and inhibit the IKK/IκBα/NF-κB pathway to reduce neuronal inflammation, oxidative stress and enhance the survival of DA neurons in the brains of PD mice (Yan et al., 2019). Here, NFKB1 is linked to Parkinson disease.